Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $37.6 Million - $42.5 Million
147,181 Added 154.77%
242,275 $69.8 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $522,792 - $649,060
2,391 Added 2.58%
95,094 $25.6 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $1.45 Million - $1.72 Million
6,772 Added 7.88%
92,703 $20.6 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $1.11 Million - $1.36 Million
4,933 Added 6.09%
85,931 $20.8 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $844,433 - $1.07 Million
3,687 Added 4.77%
80,998 $21.3 Million
Q3 2022

Nov 15, 2022

BUY
$224.46 - $253.15 $1.31 Million - $1.48 Million
5,843 Added 8.18%
77,311 $17.4 Million
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $2.12 Million - $2.36 Million
9,208 Added 14.79%
71,468 $17.4 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $1.62 Million - $1.79 Million
7,379 Added 13.45%
62,260 $15.1 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $1.34 Million - $1.53 Million
-6,714 Reduced 10.9%
54,881 $12.3 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $1.88 Million - $2.21 Million
8,868 Added 16.82%
61,595 $13.1 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $942,728 - $1.05 Million
-4,036 Reduced 7.11%
52,727 $12.9 Million
Q1 2021

Aug 10, 2021

BUY
$221.91 - $258.6 $1.01 Million - $1.18 Million
4,572 Added 8.76%
56,763 $14.1 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $1 Million - $1.17 Million
4,519 Added 9.48%
52,191 $13 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $371,308 - $442,161
1,716 Added 3.73%
47,672 $11 Million
Q3 2020

Dec 10, 2020

BUY
$234.65 - $260.95 $293,312 - $326,187
1,250 Added 2.8%
45,956 $11.7 Million
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $537,449 - $659,524
2,717 Added 6.47%
44,706 $10.5 Million
Q1 2020

May 18, 2020

BUY
$182.24 - $241.7 $798,757 - $1.06 Million
4,383 Added 11.66%
41,989 $8.51 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $1.53 Million - $1.97 Million
8,100 Added 27.45%
37,606 $9.07 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $1.67 Million - $2 Million
9,605 Added 48.26%
29,506 $5.71 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $95,852 - $112,360
575 Added 2.98%
19,901 $3.67 Million
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $820,426 - $924,799
4,536 Added 30.67%
19,326 $3.67 Million
Q1 2019

Apr 12, 2019

BUY
$180.87 - $203.88 $2.68 Million - $3.02 Million
14,790 New
14,790 $2.88 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $143B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.